Healthcare -
Biotechnology - NASDAQ - US
$ 1.86
-6.06 %
$ 132 M
Market Cap
-1.16
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Nkarta, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 128 M |
| Operating Income | -128 M |
| Other Expenses | -19.4 M |
| Net Income | -109 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0.1 | 6.5 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0 | 5.9 | 6.6 | 2.1 | 1.0 | 17.2 K | 4.3 |
| Gross Profit | 0 | (5.9) | (6.6) | (2.1) | (1.0) | 98.2 K | 2.3 |
| OPERATING INCOME | |||||||
| Operating Expenses | 128.2 | 131.7 | 119.0 | 86.4 | 51.5 | 22.5 | 6.9 |
| Selling, General and Administrative Expenses | 31.4 | 34.9 | 28.1 | 23.0 | 15.3 | 5.2 | 2.7 |
| Research and Development Expenses | 87.6 | 90.9 | 90.9 | 63.4 | 36.2 | 17.2 | 4.3 |
| Operating Income | (128.2) | (131.7) | (119.0) | (86.4) | (51.5) | (22.3) | (0.4) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 0 | 0 | 5.6 | 0 | 0 | 0.5 | 0 |
| Total Other Income | 19.4 | 14.1 | 5.1 | 0.4 | (39.9) | 1.3 | 81.9 K |
| Pre-Tax Income | (108.8) | (117.5) | (113.8) | (86.1) | (91.4) | (21.1) | (0.3) |
| NET INCOME | |||||||
| Tax Provision | 0 | 0 | 5.6 | (2.1) | (41.0) | 1.8 | 81.9 K |
| Net Income | (108.8) | (117.5) | (119.4) | (83.9) | (50.4) | (22.9) | (0.3) |
| EPS | 1.6 | 2.4 | 2.74 | 2.55 | 1.59 | 2.55 | 0.0001 |